青少年及儿童分化型甲状腺癌临床特征及治疗策略

李树春, 李振东, 刘宏伟, 等. 青少年及儿童分化型甲状腺癌临床特征及治疗策略[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(6): 431-437. doi: 10.13201/j.issn.1001-1781.2017.06.006
引用本文: 李树春, 李振东, 刘宏伟, 等. 青少年及儿童分化型甲状腺癌临床特征及治疗策略[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(6): 431-437. doi: 10.13201/j.issn.1001-1781.2017.06.006
LI Shuchun, LI Zhendong, LIU Hongwei, et al. The clinical characteristics and treatment strategies of differentiated thyroid carcinoma in adolescents and children[J]. J Clin Otorhinolaryngol Head Neck Surg, 2017, 31(6): 431-437. doi: 10.13201/j.issn.1001-1781.2017.06.006
Citation: LI Shuchun, LI Zhendong, LIU Hongwei, et al. The clinical characteristics and treatment strategies of differentiated thyroid carcinoma in adolescents and children[J]. J Clin Otorhinolaryngol Head Neck Surg, 2017, 31(6): 431-437. doi: 10.13201/j.issn.1001-1781.2017.06.006

青少年及儿童分化型甲状腺癌临床特征及治疗策略

详细信息
    通讯作者: 李振东, E-mail:1349946150@qq.com
  • 中图分类号: R736.1

The clinical characteristics and treatment strategies of differentiated thyroid carcinoma in adolescents and children

More Information
  • 目的: 探讨青少年及儿童分化型甲状腺癌患者的临床特征和治疗策略。方法: 我科1983-2014年间共收治2 936例甲状腺癌患者,其中有85例青少年及儿童分化型甲状腺癌,其中女61例,男24例;年龄9~21岁(中位年龄18.3岁), ≤ 14岁者12例。85例中乳头状癌76例,滤泡状癌9例。对85例患者的临床资料、病史、症状表现、TNM分级、组织病理学特征、治疗方法和最后转归随访结果进行分析和研究。结果: 85例青少年及儿童患者生存率为100%,随访0.5~31.0年,中位随访10.9年,10年肿瘤无进展生存率为87.1%。全组无死亡病例,出现复发患者8例(9.4%),均经再次手术治愈。有甲状腺外广泛侵犯者20例,其中 ≤ 14岁者甲状腺被膜外侵率为66.7%(8/12),明显高于 ≥ 15岁以上者的16.4%(12/73),二者差异有统计学意义(P<0.01)。有淋巴结转移者49例(57.6%),其中 ≤ 14岁者转移率占92.0%(11/12),高于 ≥ 15岁以上者的52.1%(38/73),差异有统计学意义(P<0.05)。3例在就诊时发现有肺转移,均为 ≤ 14岁患者。85例患者均进行了手术治疗,原发病灶甲状腺切除范围包括甲状腺全切、次全切和一侧腺叶切除。颈淋巴结清除方式包括改良式颈清扫、根治式颈清扫以及无颈淋巴清扫手术。全组术后接受131I放疗者15例,一次量50~170 mCi。85例患者术后均给予甲状腺刺激素抑制治疗。术后出现各种并发症13 例(15.3%),常见为喉返神经麻痹和低血钙症。结论: 青少年及儿童甲状腺癌多为乳头状癌,其次为滤泡状癌,容易发生甲状腺包膜外侵犯,淋巴结和远处转移率很高,尤其是 ≤ 14岁的儿童患者比 ≥ 15岁者更为明显,但预后良好很少因甲状腺癌死亡。主要依靠外科手术彻底切除治疗,除有远处转移和肿瘤广泛周围侵犯者需行甲状腺全或次全切除,并注意保留喉返神经和甲状旁腺功能外,多数患者局限在一侧叶者可行单侧腺叶切除。颈淋巴结转移需做改良式颈清扫,尽量避免根治性颈清扫手术,131I内照射治疗适应证需严格掌握,避免过度治疗。
  • 加载中
  • [1]

    DAVID S C, GERARD M D, BRYAN R H, et al.Revised American thyroid associatiion management guidline for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid, 2009, 19:1167-1214.

    [2]

    ROSE J, WERTHEIM B C, GUERRERO M A.Radiation treatment of patients with primary pediatric malignancies:risk of developing thyroid cancer as a secondary malignancy[J].Am J Surg, 2012, 204:881-886.

    [3]

    TRONKO M D, BOGDANOVA T I, KOMISSARENKO I V, et al.Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident[J].Cancer, 1999, 86:149-156.

    [4]

    REINERS C, DEMIDCHIK Y E, DROZD V M, et al.Thyroid cancer in infants and adolescents after Chyrnobyl[J].Minerva Endocrinol, 2008, 33:381-395.

    [5]

    SHAHA A R.Controversies in the management of thyroid nodule[J].Laryngoscope, 2000, 110:183-193.

    [6]

    OAKLEY G M, CURTIN K, PIMENTEL R, et al.Establishing a familial basis for papillary carcinoma using the Utah population database[J].JAMA Otolaryngol Head Neck Surg, 2013, 139:1171-1174.

    [7]

    THOMPSON G B, HAY I D.Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma[J].World J Surg, 2004, 28:1187-1198.

    [8]

    李树玲.新编头颈肿瘤学[M].北京:科学技术出版社, 2002:873-873.

    [9]

    JEFFREY J H, GORDEN H S, NELLA F, et al.Thyroid fine-needle aspiration:does case volume affect diagnostic yield and interpretation[J]?Arch Otolaryngol Head Neck Surg, 2011, 137:1136-1139.

    [10]

    YOO F, CHAIKHOUTDINOV I, MITZNER R, et al.Characteristics of incidentally discovered thyroid cancer[J].JAMA Otolaryngol Head Neck Surg, 2013, 139:1181-1186.

    [11]

    GRIGSBY P W, GAL-OR A, MICHALSKI J M, et al.Childhood and adolescent thyroid carcinoma[J].Cancer, 2002, 95:724-729.

    [12]

    MICHAEL A R, CHRISTOPHER R M.Central neck dissection for papillary thyroid cancer[J].Arch Otolaryngol Head Neck Surg, 2009, 135:1092-1097.

    [13]

    BRYAN R H, ERIK K A, KEITH C B, et al.2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid, 2015, 10:147-149.

    [14]

    李会政, 唐平章, 徐震纲, 等.青少年分化型甲状腺癌治疗及预后[J].中国耳鼻咽喉头颈外科, 2008, 15 (1):15-18.

    [15]

    徐震纲, 刘绍严, 屠规益.甲状腺全切除的是与非[J].中华肿瘤杂志, 2011, 33 (7):554-555.

    [16]

    NEWMAN K D, BLACK T, HELLER G, et al.Differentiated thyroid cancer:determinants of disease progression in patients<21years of age at diagnosis:a report from the surgical committee of the children's cancer group[J].Ann Surg, 1998, 227:533-541.

  • 加载中
计量
  • 文章访问数:  175
  • PDF下载数:  153
  • 施引文献:  0
出版历程
收稿日期:  2016-11-05

目录